Start with its own history
At 0.31×, ACH is 99.1% below its 5-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.
NYSE · ACHMedical - DistributionUpdated Oct 22, 2026
Accendra Health, Inc. P/E ratio
Current valuation, historical context, and peer comparisons.
Current P/E ratio
0.31×
99.1% belowthe 5-observation annual average
Share price0.2108
÷Earnings per share0.68
Price and EPS in quote currency. Calculation details
Investors are paying 0.31 for every 1 of reported earnings per share.
P/E over time
2016 – 2025
Annual P/ESelected-period average 34.54×
3-year averageN/M0 positive annual observations
5-year average39.68×2 positive annual observations
10-year average34.54×5 positive annual observations
Peer median · TTMN/M0 peers with positive P/E
Historical P/E ratios
Annual period-end data · 25 observations
| Period end | P/E | Change |
|---|---|---|
| Dec 31, 2025 | N/M | N/M |
| Dec 31, 2024 | N/M | N/M |
| Dec 31, 2023 | N/M | N/M |
| Dec 31, 2022 | 65.10× | +356.4% |
| Dec 31, 2021 | 14.26× | -75.2% |
| Dec 31, 2020 | 57.55× | N/M |
| Dec 31, 2019 | N/M | N/M |
| Dec 31, 2018 | N/M | N/M |
View all 25 annual observations +
| Period end | P/E | Change |
|---|---|---|
| Dec 31, 2017 | 15.73× | -21.5% |
| Dec 31, 2016 | 20.05× | -8.0% |
| Dec 31, 2015 | 21.81× | -34.2% |
| Dec 31, 2014 | 33.12× | +59.5% |
| Dec 31, 2013 | 20.77× | +25.3% |
| Dec 31, 2012 | 16.58× | +8.6% |
| Dec 31, 2011 | 15.27× | -8.7% |
| Dec 31, 2010 | 16.72× | -1.8% |
| Dec 31, 2009 | 17.04× | +3.8% |
| Dec 31, 2008 | 16.41× | -29.8% |
| Dec 31, 2007 | 23.38× | -9.2% |
| Dec 31, 2006 | 25.74× | +52.8% |
| Dec 31, 2005 | 16.84× | -7.7% |
| Dec 31, 2004 | 18.23× | +26.1% |
| Dec 31, 2003 | 14.46× | +22.9% |
| Dec 31, 2002 | 11.77× | -56.1% |
| Dec 31, 2001 | 26.81× | N/M |
Change is relative to the preceding observation. N/M values are excluded from averages.
How ACH compares
Company P/E vs. peer trailing-12-month ratios
| Company | P/E ratio |
|---|---|
 ACH This stockAccendra Health, Inc. | 0.31× |
 SGHTSight Sciences, Inc. | N/M |
 OMOutset Medical, Inc. | N/M |
 CVRXCVRx, Inc. | N/M |
 ACRSAclaris Therapeutics, Inc. | N/M |
 BIOABioAge Labs Inc. | N/M |
 EDITEditas Medicine, Inc. | N/M |
 ALLOAllogene Therapeutics, Inc. | N/M |
 CGCCanopy Growth Corporation | N/M |
Peers are selected by the data provider. Business models and earnings definitions can differ.
Put the numbers in context
What does ACH’s P/E tell you?
Compare like with like
Peer ratios add context to the company's own history. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.
Check what drives earnings
One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.
Keep your research connected
Take ACH into your spreadsheet
Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.
Explore WisesheetsQuarterly P/E · latest quarterLQ selects the latest reported quarter. Requires the Wisesheets add-in. See available data
=WISE("ACH", "PE Ratio", "LQ")Sources & calculation methodology
Current P/E
Share price 0.2108 ÷ EPS 0.68 = 0.31×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Oct 22, 2026; this is not a real-time trading quote.
History & averages
Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.
Data definitions and limitations
The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.
ACH P/E ratio: common questions
The essentials behind the numbers.
Accendra Health, Inc.'s current P/E is 0.31× based on the quote data last updated Oct 22, 2026. It represents the share price divided by reported earnings per share. Prices and earnings may refresh on different schedules.
Annual P/E uses earnings for a completed fiscal year. Trailing-12-month (TTM) P/E uses the latest four quarters, while forward P/E uses forecast earnings. These are not interchangeable. This page labels peer ratios as TTM and shows dated annual or quarterly historical observations; it does not show forward estimates.
N/M means not meaningful: the feed has no positive P/E for that observation. Negative or zero earnings should not be ranked as a low positive valuation multiple. N/M observations are excluded from the averages shown above.
Divide the share price by earnings per share (EPS). For example, a share price of 100 and EPS of 5 gives a P/E of 20×. This page uses the price and EPS supplied together in the quote when both are positive.
Price timestamps, EPS definitions, share classes, adjustments, and fiscal periods can differ. A forward P/E also uses forecast earnings rather than reported earnings. Compare the inputs and as-of dates before comparing two displayed ratios.
Not necessarily. The average describes previous market pricing, not fair value. Changes in earnings quality, growth expectations, debt, accounting, and business risk can justify a different multiple today.